Back to Results
First PageMeta Content
General practice / Headaches / Sinusitis / Sinus / Mometasone furoate / Medicine / Rhinology / Otolaryngology


Intersect ENT Announces Publication of Positive Data from Three Studies of Company’s Drug-Eluting Sinus Implants Results Published in International Forum of Allergy & Rhinology Add to Clinical Evidence Supporting Benef
Add to Reading List

Document Date: 2014-10-08 16:52:23

Open Document

File Size: 30,88 KB

Share Result on Facebook

City

Orlando / Frisco / /

Company

Intersect ENT Inc. / /

Country

United States / /

Event

FDA Phase / /

MedicalCondition

chronic infections / sinus inflammation / chronic sinusitis undergoing ethmoid sinus surgery / inflammation / chronic sinusitis / inflammatory condition leading / /

MedicalTreatment

sinus surgery / surgery / /

Organization

FDA / American Rhinologic Society / /

Person

Lisa Earnhardt / Keith Matheny / /

Position

physician / ENT physician / president and CEO / /

Product

Local Drug / mometasone furoate / PROPEL / Company / /

ProvinceOrState

Texas / Florida / California / /

Technology

Drug Delivery / /

SocialTag